MMWR Morbidity and Mortality Weekly Report · 2022 · 366 citations · 6 references
Veterinary MedicineInfectious Disease ControlInfectious DiseasesEpidemiologyImmunizationInfectious Disease EpidemiologyAdult ImmunizationAdverse Events Following ImmunizationImmunization EpidemiologyVaccinationVaccine SafetyVaccine Safety SurveillanceDeath RatesStandardized Death RatesVaccination Status AscertainmentVariant Emergence Studies
A COVID-19 case in a fully vaccinated person occurred when SARS-CoV-2 RNA or antigen was detected in a respiratory specimen collected 14 days after completing the primary series of a COVID-19 vaccine with Food and Drug Administration (FDA) approval or emergency use authorization. The COVID-19 case definition, including criteria to distinguish a new case from an existing case, is per the July 2021 update to the national standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19) (21-ID-01) (https://ndc.services.cdc.gov/case-definitions/ coronavirus-disease-2019-2021/). Fully vaccinated persons were those with a completed primary series of 2 doses of the Pfizer-BioNTech or Moderna mRNA vaccine or a single dose of the Janssen vaccine (https://www.cdc.gov/ coronavirus/2019-ncov/vaccines/stay-up-to-date.html). A COVID-19 case in an unvaccinated person occurred when the person did not receive any FDAauthorized COVID-19 vaccine doses before the specimen collection date. Cases were excluded in partially vaccinated persons who received at least one FDAauthorized or approved vaccine dose but did not complete a primary series 14 days before collection of a respiratory specimen with SARS-CoV-2 RNA or antigen detected. Ascertaining vaccination status for COVID-19 patients through active linkage of case surveillance and immunization information systems typically assumes that cases among persons who are unmatched to the registry are unvaccinated. This analysis represents the combined impact of the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines, which had different clinical efficacies against confirmed infection. Information on different FDA-authorized and approved COVID-19 vaccine products, including clinical efficacy, is available online. https://www.cdc.gov/coronavirus/2019-ncov/ vaccines/different-vaccines.html
6
Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra et al. · JAMA · 2022 · 683 citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +17
Heather M. Scobie, Amelia G. Johnson, Amitabh B. Suthar et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 319 citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +13
Hannah E. Fast, Elizabeth R. Zell, Bhavini Patel Murthy et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 44 citations · Full text
Veterinary Medicine, Infectious Diseases, Preventive Medicine +17